Format

Send to:

Choose Destination
See comment in PubMed Commons below
Dent Update. 2000 May;27(4):165-70, 172-4.

Antimycotic agents in oral candidosis: an overview: 2. Treatment of oral candidosis.

Author information

  • 1Department of Oral Medicine & Periodontology, Faculty of Dental Sciences, University of Peradeniya, Sri Lanka.

Abstract

As both humans and fungi are eukaryotic organisms, antifungal agents affect their cellular metabolism. Thus, a relatively few antifungals with minimal toxicity and side-effects are available compared with a plethora of antibacterials. These agents currently prescribed in dentistry belong to two major groups, the polyenes (nystatin and amphotericin B) and the azoles (imidazoles and triazoles). A newly recognized phenomenon known as the post-antifungal effect implies that antifungals, even at sub-therapeutic concentrations, may suppress the virulent attributes of yeasts, especially intra-orally where topical drug levels fluctuate dramatically during dosing intervals.

PMID:
11218451
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk